{"id":5955,"date":"2022-11-15T13:19:51","date_gmt":"2022-11-15T12:19:51","guid":{"rendered":"https:\/\/blog.caixaresearch.org\/?p=5955"},"modified":"2023-01-10T16:32:42","modified_gmt":"2023-01-10T15:32:42","slug":"covid-19-persistent-que-en-sabem","status":"publish","type":"post","link":"https:\/\/blog.caixaresearch.org\/ca\/covid-19-persistent-que-en-sabem\/","title":{"rendered":"COVID-19 persistent: qu\u00e8 en sabem?"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-5965\" src=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/11\/Org_Captacio_1_CAT-1-1-300x157.jpg\" alt=\"\" width=\"400\" height=\"209\" srcset=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/11\/Org_Captacio_1_CAT-1-1-300x157.jpg 300w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/11\/Org_Captacio_1_CAT-1-1-1024x535.jpg 1024w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/11\/Org_Captacio_1_CAT-1-1-768x401.jpg 768w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/11\/Org_Captacio_1_CAT-1-1-1536x802.jpg 1536w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/11\/Org_Captacio_1_CAT-1-1-2048x1070.jpg 2048w\" sizes=\"auto, (max-width: 400px) 100vw, 400px\" \/><\/p>\n<p><strong>23<\/strong><b> de novembre, a les 19 h, debat presencial en el Museu de la ci\u00e8ncia CosmoCaixa i retransmissi\u00f3 en l\u00ednia en<\/b><b><i> streaming. <a href=\"https:\/\/fundacionlacaixa.org\/ca\/debats-caixaresearch-covid-19-persistent\">Apunta-t&#8217;hi aqu\u00ed<\/a>.<\/i><\/b><\/p>\n<p><span style=\"font-weight: 400;\">Ja fa m\u00e9s de dos anys que estem immersos en una pand\u00e8mia que ha provocat gaireb\u00e9 600\u00a0milions de casos confirmats i m\u00e9s de 6,5 milions de morts oficials, tot i que s\u2019estima que la xifra real de morts arriba a m\u00e9s de 20 milions.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Per\u00f2, aix\u00ed com la majoria de les persones que desenvolupen la COVID-19 es recuperen completament de la malaltia aguda, que pot durar de 7 a 20 dies, l\u2019Organitzaci\u00f3 Mundial de la Salut (OMS) calcula que aproximadament entre el 10 i el 20\u00a0% de la poblaci\u00f3 experimenta diversos efectes a mitj\u00e0 i llarg termini despr\u00e9s de recuperar-se de la malaltia inicial. Aquests efectes a mitj\u00e0 i llarg termini es coneixen avui com a <\/span><i><span style=\"font-weight: 400;\">covid de llarga durada <\/span><\/i><span style=\"font-weight: 400;\">(<\/span><i><span style=\"font-weight: 400;\">long-covid<\/span><\/i><span style=\"font-weight: 400;\">) o <\/span><i><span style=\"font-weight: 400;\">covid persistent<\/span><\/i><span style=\"font-weight: 400;\">, i difereixen dels efectes que t\u00e9 la covid en pacients immunodeprimits o especialment vulnerables.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Aquesta nova malaltia relacionada amb la covid \u00e9s encara molt desconeguda, com ho s\u00f3n tamb\u00e9 les seves causes, i ha estat silenciada, infradiagnosticada i infratractada durant molts mesos. En un proc\u00e9s dirigit des de Ginebra per l\u2019OMS, es va coordinar un panell internacional de 265 pacients, metges, investigadors i personal de l\u2019OMS per desenvolupar una definici\u00f3 de consens per a aquesta afecci\u00f3 tan complexa.<\/span><\/p>\n<p style=\"padding-left: 40px;\"><em>Definici\u00f3 de covid persistent<\/em><\/p>\n<p style=\"padding-left: 40px;\"><em>\u00c9s l\u2019afecci\u00f3 que es dona en individus amb antecedents d\u2019infecci\u00f3 probable o confirmada per SARS-CoV-2, generalment 3 mesos despr\u00e9s de l\u2019inici, amb s\u00edmptomes que duren com a m\u00ednim 2 mesos i que no es poden explicar amb un diagn\u00f2stic alternatiu. Els s\u00edmptomes comuns inclouen, entre d\u2019altres, fatiga, dificultat per respirar i disfunci\u00f3 cognitiva, i generalment tenen un impacte en el funcionament diari. Els s\u00edmptomes poden ser de nova aparici\u00f3 despr\u00e9s de la recuperaci\u00f3 inicial d\u2019un episodi agut de covid-19 o persistir des de la malaltia inicial. Els s\u00edmptomes tamb\u00e9 poden fluctuar i reapar\u00e8ixer amb el temps.<\/em><\/p>\n<p><span style=\"font-weight: 400;\">Gr\u00e0cies a estudis i publicacions recents, cada vegada tenim m\u00e9s detalls sobre la covid persistent, per\u00f2 encara se\u2019n desconeixen molts aspectes. Durant el debat intentarem dilucidar, entre d\u2019altres, aquestes q\u00fcestions: Qu\u00e8 en sabem, de les causes de la covid persistent? Quins en s\u00f3n els s\u00edmptomes principals i secundaris? En tenim dades suficients i objectives per poder-la estudiar? Els s\u00edmptomes s\u00f3n continus o es produeixen en brots? Quant de temps pot durar la malaltia? Encara hi ha metges que creuen que alguns pacients s\u2019inventen que pateixen aquesta malaltia? Diferents pacients n\u2019experimenten diferents graus? Quins tractaments hi ha actualment? Hi ha difer\u00e8ncia entre els s\u00edmptomes de les persones que han estat hospitalitzades i les que no? Qu\u00e8 passa amb les persones immunodeprimides que tenen la covid i se\u2019ls allarguen els s\u00edmptomes en el temps, tenen alguna semblan\u00e7a amb la covid persistent? Com acompanyem actualment a la sanitat espanyola els malalts de covid persistent? Amb una taxa de vacunaci\u00f3 tan elevada actualment contra la covid al nostre pa\u00eds, ha disminu\u00eft el nombre de casos de covid persistent els \u00faltims mesos?<\/span><\/p>\n<p><b>Ponents:<\/b><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Lourdes Mateu, coordinadora de la Unitat de Covid Persistent, metge especialista del Servei de Malalties Infeccioses de l\u2019Hospital Germans Trias i Pujol i professora associada de Medicina de la UAB.<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Gema Mar\u00eda Lled\u00f3 Ib\u00e1\u00f1ez, responsable de la Consulta Postcovid (<\/span><i><span style=\"font-weight: 400;\">post-covid condition<\/span><\/i><span style=\"font-weight: 400;\">), metge assistencial del Servei de Medicina Interna i del Servei de Malalties Autoimmunes Sist\u00e8miques de l\u2019Hospital Cl\u00ednic de Barcelona.<\/span><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>Llegeix la cr\u00f2nica d\u2019altres debats:<\/p>\n<ul>\n<li><a href=\"https:\/\/blog.caixaresearch.org\/ca\/nutricio-i-cancer-la-importancia-de-la-prevencio\/\">Nutrici\u00f3 i c\u00e0ncer: la import\u00e0ncia de la prevenci\u00f3.<\/a> Amb el doctor Marcos Malumbres (CNIO) i la doctora Marina Poll\u00e1n (CNE-ISCIII i CIBERESP). 27\/10\/22.<\/li>\n<li><a href=\"https:\/\/fundacionlacaixa.org\/ca\/debats-caixaresearch-ment-cervell\">Com percep el cervell el m\u00f3n i genera records?<\/a> Amb el doctor Josep Dalmau (ICREA i Hospital Cl\u00ednic) i la doctora Guillermina L\u00f3pez-Bendito (CSIC). 21\/06\/22<\/li>\n<li><a href=\"https:\/\/blog.caixaresearch.org\/ca\/curar-la-ceguesa-tractar-la-retina-per-restaurar-la-visio-2\/\" target=\"_blank\" rel=\"noopener\">Curar la ceguesa: tractar la retina per restaurar la visi\u00f3.<\/a> Amb la doctora Maria Pia Cosma (ICREA i CRG) i el doctor Jos\u00e9 Antonio Garrido (ICREA i ICN2). 25\/05\/22<\/li>\n<li><a href=\"https:\/\/blog.caixaresearch.org\/ca\/es-possible-crear-una-vacuna-universal-per-a-malalties-infeccioses-croniques-2\/\" target=\"_blank\" rel=\"noopener\">\u00c9s possible crear una vacuna universal per a malalties infeccioses cr\u00f2niques?<\/a> Amb el doctor Christian Brander (ICREA, IrsiCaixa, Aelix Therapeutics) i la doctora Valentina Casella (MELIS-UPF). 26\/04\/22<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><a href=\"https:\/\/blog.caixaresearch.org\/ca\/covid-19-com-hi-haurem-de-conviure-2\/\"><span style=\"font-weight: 400;\">COVID-19: Com hi haurem de conviure?<\/span><\/a> <span style=\"font-weight: 400;\">Amb el doctor Antoni Trilla (Hospital Cl\u00ednic de Barcelona, UB i ISGlobal) i la doctora Clara Prats (UPC i IGTP). 23\/03\/22<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><a href=\"https:\/\/fundacionlacaixa.org\/ca\/debats-caixaresearch-malalties-minoritaries\"><span style=\"font-weight: 400;\">Malalties minorit\u00e0ries: Per qu\u00e8 el 95\u00a0% no tenen tractament?<\/span><\/a> <span style=\"font-weight: 400;\">Amb els doctors Pablo Lapunzina i V\u00edctor Mart\u00ednez Gonz\u00e1lez (CIBERER i IdiPAZ). 23\/02\/2022<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><a href=\"https:\/\/blog.caixaresearch.org\/ca\/cancer-infantil-moltes-malalties-sense-tractaments-especifics\/\"><span style=\"font-weight: 400;\">C\u00e0ncer infantil: moltes malalties sense tractaments espec\u00edfics<\/span><\/a><span style=\"font-weight: 400;\">. Amb el doctor Jaume Mora (PCCB) i la doctora Ana Pati\u00f1o (Cl\u00ednica Universidad de Navarra). 24\/01\/2022<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><a href=\"https:\/\/blog.caixaresearch.org\/ca\/40-anos-de-sida-para-cuando-una-cura-o-una-vacuna\/\"><span style=\"font-weight: 400;\">40 anys de sida: Quan tindrem una cura o una vacuna?<\/span><\/a> <span style=\"font-weight: 400;\">Amb el doctor Juli\u00e0 Blanco i la doctora Beatriz Mothe (IrsiCaixa). 29\/11\/2021<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><a href=\"https:\/\/blog.caixaresearch.org\/ca\/nadons-prematurs-extrems-augmentant-la-seva-supervivencia\/\"><span style=\"font-weight: 400;\">Nadons prematurs extrems: augmentant la seva superviv\u00e8ncia<\/span><\/a><span style=\"font-weight: 400;\">. Amb el doctor Eduard Gratac\u00f3s (BCNatal) i la doctora Adelina Pellicer (H. U. La Paz). 17\/11\/2021<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><a href=\"https:\/\/blog.caixaresearch.org\/ca\/com-abordem-les-malalties-del-cor-primera-causa-de-mortalitat-mundial\/\"><span style=\"font-weight: 400;\">Com abordem les malalties del cor? Primera causa de mortalitat mundial<\/span><\/a><span style=\"font-weight: 400;\">. Amb el doctor Valent\u00ed Fuster (CNIC), la doctora Judit Cubedo (GlyCardial Diagnostics) i la doctora Gloria Santos (Fundaci\u00f3 SHE). 29\/09\/2021<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><a href=\"https:\/\/blog.caixaresearch.org\/ca\/ela-una-malaltia-mortal-per-molt-de-temps\/\"><span style=\"font-weight: 400;\">ELA, una malaltia mortal\u2026 per molt de temps?<\/span><\/a> <span style=\"font-weight: 400;\">Amb la doctora Carmen M. Fern\u00e1ndez-Martos (HNP) i el doctor Rub\u00e8n L\u00f3pez Vales (UBNeuro). 17\/06\/2021<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><a href=\"https:\/\/blog.caixaresearch.org\/ca\/podrem-curar-lobesitat-una-pandemia-del-segle-xxi\/\"><span style=\"font-weight: 400;\">Podrem curar l\u2019obesitat? Una pand\u00e8mia del segle <\/span><span style=\"font-weight: 400;\">xxi<\/span><\/a><span style=\"font-weight: 400;\">. Amb el doctor Miguel L\u00f3pez (CiMUS) i la doctora Sonia Fern\u00e1ndez Veledo (IISPV). 27\/05\/2021<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><a href=\"https:\/\/blog.caixaresearch.org\/ca\/nous-reptes-en-vacunacio-i-erradicacio-de-malalties\/\"><span style=\"font-weight: 400;\">Nou reptes en vacunaci\u00f3 i erradicaci\u00f3 de malalties<\/span><\/a><span style=\"font-weight: 400;\">. Amb el doctor Pedro Alonso (OMS) i la doctora Regina Rabinovich (ISGlobal). 22\/04\/2021<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><a href=\"https:\/\/blog.caixaresearch.org\/ca\/leucemia-present-i-futur-dels-nous-tractaments\/\"><span style=\"font-weight: 400;\">Leuc\u00e8mia, present i futur dels nous tractaments<\/span><\/a><span style=\"font-weight: 400;\">. Amb el doctor El\u00edas Campo (IDIBAPS) i la doctora Biola Javierre (Institut d\u2019Investigaci\u00f3 contra la Leuc\u00e8mia Josep Carreras). 25\/03\/2021<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><a href=\"https:\/\/blog.caixaresearch.org\/ca\/dones-en-ciencia-superant-estereotips-i-desigualtats\/\"><span style=\"font-weight: 400;\">Dones en ci\u00e8ncia, superant estereotips i desigualtats<\/span><\/a><span style=\"font-weight: 400;\">. Amb les doctores Blanca Fuentes (IdiPAZ), Carmen Gil (CIB-CSIC), Almudena Ramiro (CNIC), Mar\u00eda Soledad Soengas (CNIO) i Gemma Triola (ICAQ-CSIC). 11\/02\/2021<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><a href=\"https:\/\/blog.caixaresearch.org\/ca\/vacunes-la-gran-resposta-contra-la-covid-19\/\"><span style=\"font-weight: 400;\">Vacunes, la gran resposta contra la COVID-19<\/span><\/a><span style=\"font-weight: 400;\">. Amb el doctor Mariano Esteban (CNB-CSIC) i la doctora Denise Naniche (ISGlobal). 26\/01\/2021<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><a href=\"https:\/\/blog.caixaresearch.org\/ca\/els-cervells-que-combaten-la-malaltia-dalzheimer\/\"><span style=\"font-weight: 400;\">Objectiu: prevenir la malaltia d&#8217;Alzheimer. Un repte cient\u00edfic i social<\/span><\/a><span style=\"font-weight: 400;\">. Amb la doctora Merc\u00e8 Boada (Fundaci\u00f3 ACE) i el doctor Arcadi Navarro (Fundaci\u00f3 Pasqual Maragall). 17\/11\/2020<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><a href=\"https:\/\/blog.caixaresearch.org\/ca\/cancer-cap-a-on-sorienten-les-noves-terapies\/\"><span style=\"font-weight: 400;\">C\u00e0ncer. Cap a on s&#8217;orienten les noves ter\u00e0pies?<\/span><\/a><span style=\"font-weight: 400;\"> Amb la doctora Mar\u00eda Blasco (CNIO) i el doctor Josep Tabernero (VHIO). 20\/10\/2020<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><a href=\"https:\/\/blog.caixaresearch.org\/ca\/lexit-dels-tractaments-ja-disponibles-per-a-pacients-amb-covid-19\/\"><span style=\"font-weight: 400;\">L\u2019\u00e8xit dels tractaments ja disponibles per a pacients amb COVID-19<\/span><\/a><span style=\"font-weight: 400;\">. Amb els doctors Bonaventura Clotet (IrsiCaixa) i Valent\u00ed Fuster (CNIO). 22\/09\/2020<\/span><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-5965\" src=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/11\/Org_Captacio_1_CAT-1-1-300x157.jpg\" alt=\"\" width=\"400\" height=\"209\" srcset=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/11\/Org_Captacio_1_CAT-1-1-300x157.jpg 300w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/11\/Org_Captacio_1_CAT-1-1-1024x535.jpg 1024w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/11\/Org_Captacio_1_CAT-1-1-768x401.jpg 768w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/11\/Org_Captacio_1_CAT-1-1-1536x802.jpg 1536w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/11\/Org_Captacio_1_CAT-1-1-2048x1070.jpg 2048w\" sizes=\"auto, (max-width: 400px) 100vw, 400px\" \/><\/p>\n<p>23 de novembre, a les 19 h, debat presencial en el Museu de la ci\u00e8ncia CosmoCaixa i retransmissi\u00f3 en l\u00ednia en<i> streaming. <a href=\"https:\/\/fundacionlacaixa.org\/ca\/debats-caixaresearch-covid-19-persistent\">Apunta-t&#8217;hi aqu\u00ed<\/a>.<\/i><\/p>\n<p>Ja fa m\u00e9s de dos anys que estem immersos en una pand\u00e8mia que ha provocat gaireb\u00e9 600\u00a0milions de casos confirmats i m\u00e9s de 6,5 milions de morts oficials, tot i que s\u2019estima que la xifra real de morts arriba a m\u00e9s de 20 milions.<\/p>\n<p>Per\u00f2, aix\u00ed com la majoria de les persones que desenvolupen la COVID-19 es recuperen completament de la malaltia aguda, que pot durar de 7 a 20 dies, l\u2019Organitzaci\u00f3 Mundial de la Salut (OMS) calcula que aproximadament entre el 10 i el 20\u00a0% de la poblaci\u00f3 experimenta diversos efectes a mitj\u00e0 i llarg termini despr\u00e9s de recuperar-se de la malaltia inicial.<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[340],"tags":[],"class_list":["post-5955","post","type-post","status-publish","format-standard","hentry","category-sense-categoria"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>COVID-19 persistent: qu\u00e8 en sabem? - Blog CaixaCi\u00e8ncia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blog.caixaresearch.org\/ca\/covid-19-persistent-que-en-sabem\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"COVID-19 persistent: qu\u00e8 en sabem? - Blog CaixaCi\u00e8ncia\" \/>\n<meta property=\"og:description\" content=\"23 de novembre, a les 19 h, debat presencial en el Museu de la ci\u00e8ncia CosmoCaixa i retransmissi\u00f3 en l\u00ednia en streaming. Apunta-t&#8217;hi aqu\u00ed. Ja fa m\u00e9s de dos anys que estem immersos en una pand\u00e8mia que ha provocat gaireb\u00e9 600\u00a0milions de casos confirmats i m\u00e9s de 6,5 milions de morts oficials, tot i que s\u2019estima que la xifra real de morts arriba a m\u00e9s de 20 milions. Per\u00f2, aix\u00ed com la majoria de les persones que desenvolupen la COVID-19 es recuperen completament de la malaltia aguda, que pot durar de 7 a 20 dies, l\u2019Organitzaci\u00f3 Mundial de la Salut (OMS) calcula que aproximadament entre el 10 i el 20\u00a0% de la poblaci\u00f3 experimenta diversos efectes a mitj\u00e0 i llarg termini despr\u00e9s de recuperar-se de la malaltia inicial.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blog.caixaresearch.org\/ca\/covid-19-persistent-que-en-sabem\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog CaixaCi\u00e8ncia\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-15T12:19:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-01-10T15:32:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/11\/Org_Captacio_1_CAT-1-1-300x157.jpg\" \/>\n<meta name=\"author\" content=\"Ubikmedia\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ubikmedia\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/blog.caixaresearch.org\/ca\/covid-19-persistent-que-en-sabem\/\",\"url\":\"https:\/\/blog.caixaresearch.org\/ca\/covid-19-persistent-que-en-sabem\/\",\"name\":\"COVID-19 persistent: qu\u00e8 en sabem? - Blog CaixaCi\u00e8ncia\",\"isPartOf\":{\"@id\":\"https:\/\/blog.caixaresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/blog.caixaresearch.org\/ca\/covid-19-persistent-que-en-sabem\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/blog.caixaresearch.org\/ca\/covid-19-persistent-que-en-sabem\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/11\/Org_Captacio_1_CAT-1-1-300x157.jpg\",\"datePublished\":\"2022-11-15T12:19:51+00:00\",\"dateModified\":\"2023-01-10T15:32:42+00:00\",\"author\":{\"@id\":\"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/2b9d5310c27055b4862191402c387fca\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/blog.caixaresearch.org\/ca\/covid-19-persistent-que-en-sabem\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/blog.caixaresearch.org\/ca\/covid-19-persistent-que-en-sabem\/#primaryimage\",\"url\":\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/11\/Org_Captacio_1_CAT-1-1-300x157.jpg\",\"contentUrl\":\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/11\/Org_Captacio_1_CAT-1-1-300x157.jpg\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/blog.caixaresearch.org\/#website\",\"url\":\"https:\/\/blog.caixaresearch.org\/\",\"name\":\"Blog CaixaCi\u00e8ncia\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/blog.caixaresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/2b9d5310c27055b4862191402c387fca\",\"name\":\"Ubikmedia\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ccc66bc497f8ba496f9d06e5a58a91de?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ccc66bc497f8ba496f9d06e5a58a91de?s=96&d=mm&r=g\",\"caption\":\"Ubikmedia\"},\"url\":\"https:\/\/blog.caixaresearch.org\/ca\/author\/ubikmedia\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"COVID-19 persistent: qu\u00e8 en sabem? - Blog CaixaCi\u00e8ncia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blog.caixaresearch.org\/ca\/covid-19-persistent-que-en-sabem\/","og_locale":"ca_ES","og_type":"article","og_title":"COVID-19 persistent: qu\u00e8 en sabem? - Blog CaixaCi\u00e8ncia","og_description":"23 de novembre, a les 19 h, debat presencial en el Museu de la ci\u00e8ncia CosmoCaixa i retransmissi\u00f3 en l\u00ednia en streaming. Apunta-t&#8217;hi aqu\u00ed. Ja fa m\u00e9s de dos anys que estem immersos en una pand\u00e8mia que ha provocat gaireb\u00e9 600\u00a0milions de casos confirmats i m\u00e9s de 6,5 milions de morts oficials, tot i que s\u2019estima que la xifra real de morts arriba a m\u00e9s de 20 milions. Per\u00f2, aix\u00ed com la majoria de les persones que desenvolupen la COVID-19 es recuperen completament de la malaltia aguda, que pot durar de 7 a 20 dies, l\u2019Organitzaci\u00f3 Mundial de la Salut (OMS) calcula que aproximadament entre el 10 i el 20\u00a0% de la poblaci\u00f3 experimenta diversos efectes a mitj\u00e0 i llarg termini despr\u00e9s de recuperar-se de la malaltia inicial.","og_url":"https:\/\/blog.caixaresearch.org\/ca\/covid-19-persistent-que-en-sabem\/","og_site_name":"Blog CaixaCi\u00e8ncia","article_published_time":"2022-11-15T12:19:51+00:00","article_modified_time":"2023-01-10T15:32:42+00:00","og_image":[{"url":"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/11\/Org_Captacio_1_CAT-1-1-300x157.jpg","type":"","width":"","height":""}],"author":"Ubikmedia","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"Ubikmedia","Temps estimat de lectura":"5 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/blog.caixaresearch.org\/ca\/covid-19-persistent-que-en-sabem\/","url":"https:\/\/blog.caixaresearch.org\/ca\/covid-19-persistent-que-en-sabem\/","name":"COVID-19 persistent: qu\u00e8 en sabem? - Blog CaixaCi\u00e8ncia","isPartOf":{"@id":"https:\/\/blog.caixaresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blog.caixaresearch.org\/ca\/covid-19-persistent-que-en-sabem\/#primaryimage"},"image":{"@id":"https:\/\/blog.caixaresearch.org\/ca\/covid-19-persistent-que-en-sabem\/#primaryimage"},"thumbnailUrl":"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/11\/Org_Captacio_1_CAT-1-1-300x157.jpg","datePublished":"2022-11-15T12:19:51+00:00","dateModified":"2023-01-10T15:32:42+00:00","author":{"@id":"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/2b9d5310c27055b4862191402c387fca"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blog.caixaresearch.org\/ca\/covid-19-persistent-que-en-sabem\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/blog.caixaresearch.org\/ca\/covid-19-persistent-que-en-sabem\/#primaryimage","url":"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/11\/Org_Captacio_1_CAT-1-1-300x157.jpg","contentUrl":"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2022\/11\/Org_Captacio_1_CAT-1-1-300x157.jpg"},{"@type":"WebSite","@id":"https:\/\/blog.caixaresearch.org\/#website","url":"https:\/\/blog.caixaresearch.org\/","name":"Blog CaixaCi\u00e8ncia","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blog.caixaresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Person","@id":"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/2b9d5310c27055b4862191402c387fca","name":"Ubikmedia","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ccc66bc497f8ba496f9d06e5a58a91de?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ccc66bc497f8ba496f9d06e5a58a91de?s=96&d=mm&r=g","caption":"Ubikmedia"},"url":"https:\/\/blog.caixaresearch.org\/ca\/author\/ubikmedia\/"}]}},"_links":{"self":[{"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/posts\/5955","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/comments?post=5955"}],"version-history":[{"count":5,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/posts\/5955\/revisions"}],"predecessor-version":[{"id":6057,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/posts\/5955\/revisions\/6057"}],"wp:attachment":[{"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/media?parent=5955"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/categories?post=5955"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/tags?post=5955"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}